Juyi Li

huazhong university of science and technology

H指数:16

被引数:1,982

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

A multi-fractal vascular tree model for characterizing blood flow in cardiovascular system

多分形血管树模型用于表征心血管系统中的血流

Scientific Reports

IF3.9

2026-05-270

OAAI

KNDC1 attenuates fibrosis in nonalcoholic fatty liver disease by inhibiting glycolysis in hepatic stellate cells

KNDC1通过抑制肝星状细胞的糖酵解来减轻非酒精性脂肪肝的纤维化。

Cellular Signalling

IF3.7

2026-03-130

PRE

A novel variant c.A527G in ITGB4 leads to autosomal dominant epidermolysis bullosa in China

ITGB4中的一个新变异c.A527G导致中国常染色体显性表皮松解症

Frontiers in Medicine

IF3

2026-02-080

OAAI

The non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio is associated with early onset type 2 diabetes with NAFLD: a cross-sectional study in China

非高密度脂蛋白胆固醇与高密度脂蛋白胆固醇的比值与非酒精性脂肪肝病相关的早期发病2型糖尿病有关：一项在中国进行的横断面研究

Frontiers in Nutrition

IF5.1

2025-10-310

OAAI

Molecular analysis of three DNA mismatch repair protein variants in Chinese families with suspected Lynch syndrome

中国疑似林奇综合征家庭中三种DNA错配修复蛋白变异的分子分析

Frontiers in Medicine

IF3

2025-08-080

Neighborhood Attention-Based Detection for Maize Traits in Precision Agriculture

AGRONOMY-BASEL

IF3.4

2025-04-100

Analyzing pathogenic variants in mismatch repair genes: personalized prevention strategies for lynch syndrome in Chinese families

错配修复基因的致病变异分析: 中国家庭lynch综合征的个性化预防策略

FRONTIERS IN MEDICINE

IF3

2025-03-140

OAAI

The relationship between the ratio of non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol (NHHR) and both MASLD and advanced liver fibrosis: evidence from NHANES 2017-2020

非高密度脂蛋白胆固醇与高密度脂蛋白胆固醇 (NHHR) 的比率与MASLD和晚期肝纤维化之间的关系: 来自NHANES 2017-2020的证据

FRONTIERS IN NUTRITION

IF5.1

2025-02-270

OAAI

A real-world pharmacovigilance analysis for agalsidase beta: findings from the FDA adverse event reporting database

EXPERT OPINION ON DRUG SAFETY

IF3.1

2024-12-250

PRE

Toxic Epidermal Necrolysis Observed in a Patient With the HLA-B*1502 Treated With Levofloxacin

CLINICAL THERAPEUTICS

IF3.6

2024-12-010

PRE

THSR Mediated MiR374b Targeting C/EBP β/FOXO1 to Accelerate Thyroid Stimulating Hormone-Induced Hepatic Steatosis

THSR介导MiR374b靶向C/EBP β/FOXO1以加速促甲状腺激素诱导的肝脂肪变性

hepatic medicine evidence and research

IF0

2024-11-180

OAAI

Chinese carrier of the HNF1A p.Gln444fs variant exhibits enhanced response to sulfonylureas

HELIYON

IF3.6

2024-08-010

OAAI

Investigating causal associations among gut microbiota, metabolites and autoimmune hypothyroidism: a univariable and multivariable Mendelian randomization study

FRONTIERS IN IMMUNOLOGY

IF5.9

2024-01-044

OAAI

A missense GDF5 variant causes brachydactyly type A1 and multiple-synostoses syndrome 2

JOR SPINE

IF3.9

2023-11-280

Identification of a novel CNV at the APC gene in a Chinese family with familial adenomatous polyposis

FRONTIERS IN MOLECULAR BIOSCIENCES

IF4

2023-07-271

OAAI

Association Between Educational Attainment and Thyroid Function: Results From Mendelian Randomization and the NHANES Study

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

IF5.1

2023-06-072

PRE

Association Between Systemic Lupus Erythematosus and Primary Hypothyroidism: Evidence from Complementary Genetic Methods

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

IF5.1

2022-10-205

PRE

Aqueous extract of Scrophularia ningpoensis improves insulin sensitivity through AMPK-mediated inhibition of the NLRP3 inflammasome

PHYTOMEDICINE

IF8.3

2022-09-015

PRE

Precision therapy for three Chinese families with maturity-onset diabetes of the young (MODY12)

FRONTIERS IN ENDOCRINOLOGY

IF4.6

2022-08-0311

OAAI

Two novel and one known pathogenic germline mutations in MMRs in Chinese families with Lynch syndrome

GENES & DISEASES

IF9.4

2022-03-010

OAAI

Juyi Li

个人简介

教育背景

工作经历

荣誉奖项

研究方向